Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Klein

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Immunology Letters|June 1, 1997
Kinetics of immune functions and virus replication during HIV-1 infectionO Pontesilli, M R Klein, S R Kerkhof-Garde, et al.
The Journal of General Virology|September 25, 1998
Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responsesM R Klein, S H van der Burg, E Hovenkamp, et al.
The Journal of Infectious Diseases|September 18, 1997
Longitudinal analysis of CD4 T cell counts, T cell reactivity, and human immunodeficiency virus type 1 RNA levels in persons remaining AIDS-free despite CD4 cell counts <200 for >5 yearsI P Keet, M Janssen, P J Veugelers, et al.
AIDS (London, England)|February 1, 1995
Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptaseS H van der Burg, M R Klein, C J van de Velde, et al.
The Journal of Experimental Medicine|November 14, 1997
Phenotypic and functional separation of memory and effector human CD8+ T cellsD Hamann, P A Baars, M H Rep, et al.
Infection and Immunity|November 18, 2000
Human CD8(+) T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in The GambiaS M Smith, M R Klein, A S Malin, et al.
AIDS (London, England)|April 15, 1999
Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patientsN A Foudraine, E Hovenkamp, D W Notermans, et al.
Immunology Letters|April 15, 1999
Antigen-specific T-lymphocyte proliferative responses during highly active antiretroviral therapy (HAART) of HIV-1 infectionO Pontesilli, S Kerkhof-Garde, N G Pakker, et al.
AIDS (London, England)|June 1, 1993
Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequenciesC A van Baalen, M R Klein, A M Geretti, et al.
International Journal of Molecular Medicine|December 16, 1998
Molecular analysis of critical sequences within the EBNA-2 type 1 gene from Epstein-Barr virus isolates from patients with infectious mononucleosis, tonsillar hyperplasia, and HIV infectionA S Al-Homsi, C Berger, D van Baarle, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Immunology Letters|June 1, 1997
Kinetics of immune functions and virus replication during HIV-1 infectionO Pontesilli, M R Klein, S R Kerkhof-Garde, et al.
The Journal of General Virology|September 25, 1998
Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responsesM R Klein, S H van der Burg, E Hovenkamp, et al.
The Journal of Infectious Diseases|September 18, 1997
Longitudinal analysis of CD4 T cell counts, T cell reactivity, and human immunodeficiency virus type 1 RNA levels in persons remaining AIDS-free despite CD4 cell counts <200 for >5 yearsI P Keet, M Janssen, P J Veugelers, et al.
AIDS (London, England)|February 1, 1995
Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptaseS H van der Burg, M R Klein, C J van de Velde, et al.
The Journal of Experimental Medicine|November 14, 1997
Phenotypic and functional separation of memory and effector human CD8+ T cellsD Hamann, P A Baars, M H Rep, et al.
Infection and Immunity|November 18, 2000
Human CD8(+) T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in The GambiaS M Smith, M R Klein, A S Malin, et al.
AIDS (London, England)|April 15, 1999
Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patientsN A Foudraine, E Hovenkamp, D W Notermans, et al.
Immunology Letters|April 15, 1999
Antigen-specific T-lymphocyte proliferative responses during highly active antiretroviral therapy (HAART) of HIV-1 infectionO Pontesilli, S Kerkhof-Garde, N G Pakker, et al.
AIDS (London, England)|June 1, 1993
Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequenciesC A van Baalen, M R Klein, A M Geretti, et al.
International Journal of Molecular Medicine|December 16, 1998
Molecular analysis of critical sequences within the EBNA-2 type 1 gene from Epstein-Barr virus isolates from patients with infectious mononucleosis, tonsillar hyperplasia, and HIV infectionA S Al-Homsi, C Berger, D van Baarle, et al.
Pageof 5